|
| Call for Abstracts |
| Track 1: Practical Solutions to Pharmaceutical Bioequivalence/Bioavailability Implementation |
| Track 1-1: Bioequivalence Strategies in Development-an Industry Perspective |
| Track 1-2: Comparative Bioavailability Studies for New Drugs (NDA) |
| Track 1-3: Comparative Bioavailability Generic Drug Products (ANDA): Bioequivalence Studies |
| Track 1-4: Implementing BA/BE Guidelines and CRO Qualification Criteria |
| Track 2: Pharmacokinetic/Pharmacodynamic Models, Biowaivers and Biosimilars |
| Track 2-1: Human/Animal Models in Oral Drug Absorption |
| Track 2-2: Biosimilars and Biowaivers |
| Track 2-3: Biosimulation in BE Studies-Prediction Tools |
| Track 2-4: Statistical Issues in BA/BE |
| Track 2-5: In Vivo/In Vitro Methods to Determine Bioavailability |
| Track 2-6: Role of Drug Delivery Systems in Bioequivalence and Bioavailability |
| Track 3: Bioanalytical Methodology Development and Validation Using HPLC and LCMS |
| Track 3-1: Advances in Mass Spectrometry Methodology Development |
| Track 3-2: Antiviral, Anti Retroviral, Antibacterial and Anti Fungal Drugs |
| Track 3-3: Drugs Acting on Central Nervous Systems |
| Track 3-4: Anticancer/Anti-Neovascular Drugs |
| Track 4: IP, Regulatory Affairs and Outsourcing Alliance |
| Track 4-1: Clinical Data Harmonization Across Countries |
| Track 4-2: ICH/FDA Guidelines and Regulatory Updates |
| Track 4-3: Partnerships with Animal Research Centres, Universities and Non-Profits |
| Track 4-4: Perspectives of Regulatory Agencies, Worldwide, on Bioequivalence Testing |
| Track 5: Toxicology |
| Track 5-1: Biomarkers in Toxicology |
| Track 5-2: Toxicogenomics & Metabolomics |
| Track 5-3: Environmental Toxicology |
| Track 5-4: Molecular Epidemiology |
| Track 6: PK/PD and Drug Discovery |
| Track 6-1: Anticacer, Antiviral Drug Development |
| Track 6-2: Molecular Drug Targets and Fragment based Drug Design |
| Track 6-3: Improving ADME/DMPK Profile |
| Track 6-4: PK/PD and Bioanalysis Outsourcing Alliance |
| Track 7: Bioavailability |
| Track 7-1: Influence of Disease on Bioavailability |
| Track 7-2: Factors Influencing Bioavailability and Bioequivalence |
| Track 7-3: The Role of Intestinal Metabolism on Bioavailability |
| Track 7-4: In Vitro Methods to Determine Bioavailability & In Vitro-In Vivo Correlations |
| Participants List (Academia) |
University of Notre Dame, USA
Faculty of Medicine Siriraj Mahidol University, Thailand Nova Southeastern University, USA The Australian National University Medical School, University of Canberra, Australia University of Hyderabad, India Panjab University, Chandigarh, India Institute of Biotechnology and Antibiotics, Warsaw, Poland Texas Tech School of Pharmacy, USA University of Petra, Jordan Jadavpur University, India University of British Columbia, Canada Canadian Society for Pharmaceutical Sciences, Canada National University of Singapore, Singapore King Saud University, Saudi Arabia Widener University, USA Stanford University School of Medicine, USA University at Buffalo, State University of New York, USA School of Biological Sciences, University of Edinburgh, UK Chungnam National University, Korea Harvard Medical School, USA Polish Academy of Sciences, Poland University of Trieste, Italy College of Pharmaceutical Sciences, MAHE, India Medical School, University of Athens, Greece Universiade Federal da Bahia, Instituto de Ciências da Saude, Brazil University of Region of Cariri - URCA, Brazil Tabriz University of Medical Sciences, Iran Johns Hopkins University, USA Creighton University Medical Center and University of Nebraska Medical Center, USA University of Pisa, Italy The University of Liverpool, UK
The Islamia University of Bahawalpur, Pakistan University of California, Sanfransisco, USA Al-Qassim University, College of Pharmacy Buraidah, Saudi Arabia University of Madras, India SRM University NCR Campus, India University of Peradeniya, Sri Lanka Yokohama City University, Graduate School of Medicine, Japan Radboud University Nijmegen Medical Center, The Netherlands Qilu Hospital of Shandong University, China Meerut Institute of Engineering and Technology, India Florida A & M University, College of Pharmacy, USA Jawaharlal Nehru Technological University, India Ludwig-Maximilians University, Germany V.L. College of Pharmacy, India University of Alberta, Canada Panjab University, India Monash Institute of Pharmaceutical Sciences, Monash University, Australia University of British Columbia, Brain Research Centre, Canada Univ Inst Pharm Sci (UGC Center of Adv Studies), Panjab University, India Institut Supérieur de Biotechnologies de Sfax, Tunisie All India Institute of Medical Sciences, India Rhodes University, South Africa Université Paris, France Faculty of Pharmacy, University of Ljubljana Askerceva 7, Slovenia Chungnam National University, Korea Dr H S Gour University, India National School of Public Health, Ministry of Health, Brazil University of Toronto, Canada Oncology Institute of Vojvodina , Serbia Indian Institute of Chemical Technology, India Indian Institute of Toxicology Research, India Einstein Heart and Vascular Institute, Albert Einstein Medical Center, USA University of Texas at Austin, USA National Institute for Research in Reproductive Health (ICMR), India National Cancer Institute, USA |
| Participants List (Business) |
US Pharmacopeia, USA
Food and Drug Administration, USA University Hospital Zurich, Switzerland B. V. Patel Perd Centre, India Guy's Hospital, UK Hôpital Saint-Antoine, Paris A. Manzoni Hospital, Italy Kazusa DNA Research Institute, Japan Pharmaceutics Int., Inc., USA Agilent Technologies, USA Central Drug Research Institute, India EMF Consulting, France Hopital Cochin, Paris Boys Town National Research Hospital, Omaha, USA Aurobindo Pharma Ltd., India Abbott labs, USA
Synthon BV, The Netherlands Children's Hospital Medical Center, USA Piramal Life Sciences, India AstraZeneca R&D Mölndal, Sweden Sun Pharma Advanced Research Company Limited, India Ranbaxy Research Laboratories, India University Children's Hospital Basel UKBB, Switzerland Huashan hospital of Fudan University, China Novartis Institutes for BioMedical Research, USA Defence Research and Development Canada Suffield, Canada Saudi Food and Drug Authority, Saudi Arabia Cetero Research, USA Panacea Biotec Ltd., India Lupin Ltd., India |